Melodiol Global Health Limited (ACN 609 406 911) (Company) has lodged a prospectus dated 31 October 2023 (Prospectus) with the Australian Securities and Investment Commission (ASIC):
(together, the Offer).
A target market has been specified for investors under the Bonus Options Offer, ME1OD Options Offer and Unquoted Options Offer (Target Market), which is set out in the target market determination available at www.melodiolglobalhealth.com (TMD).
The Prospectus and TMD are an important document which should be read in its entirety. If, after reading the Prospectus you have questions about the Offer, TMD or any other matter, please contact your professional advisers without delay.
Neither ASIC nor ASX Limited, nor any of their respective officers, take any responsibility for the contents of the Prospectus or the merits of the investment to which the Prospectus relates.
The electronic version of the Prospectus accessible through this website and does not constitute an offer of, or an invitation to subscribe for, any securities. You may print out a hard copy of the Prospectus from this website or copy the electronic Prospectus on this website into an electronic file for your personal use only. You must not alter the contents of this electronic file in any way.
Alternatively, you may obtain a hard copy of the Prospectus free of charge by contacting the Company by phone on +61 8 9389 3180 during office hours or by emailing the Company at email@example.com.
To the extent permitted by law, the Company is not liable for any loss incurred from accessing or downloading the Prospectus from this website, including, but not limited to, data corruption or download.
Entitlement and Acceptance
Anyone who wants to apply for their entitlement under the respective Offers will need to
Nothing contained on this website or in the Prospectus constitutes investment, legal, business, tax or other advice. In particular, the information on this website and in the Prospectus does not take into account your investment objectives, financial situation or particular needs. In making an investment decision, you must rely on your own examination of the Company and the securities and terms of the offering, including the merits and risks involved. You should consult your professional adviser for legal, business or tax advice.
For legal reasons, the electronic version of the Prospectus accessible through this website is available to persons accessing this website from within Australia, New Zealand, Germany, Canada (British Columbia, Nova Scotia, Ontario and Alberta) or United States of America (Colorado) (as instructed by the Company) who are permitted to participate in the Offer as set out in section 2.9 of the Prospectus (Approved Jurisdictions). If you are accessing this website from anywhere outside the Approved Jurisdictions, please do not download the electronic version of the Prospectus.
The Prospectus does not constitute an offer of securities in any jurisdiction where, or to any person to whom, it would not be lawful to issue the Prospectus or make the offer. It is the responsibility of any applicant outside the Approved Jurisdictions to ensure compliance with all laws of any country relevant to their applications, and any such applicant should consult their professional advisers as to whether any government or other consents are required, or whether any formalities need to be observed to enable them to apply for and be allotted any securities.
It is not practicable for the Company to comply generally with the securities laws of overseas jurisdictions having regard to the number of overseas shareholders, the number and value of securities those shareholders would be offered and the cost of complying with regulatory requirements in each relevant jurisdiction. Accordingly, the offer pursuant to the Prospectus is only being extended and securities will only be issued to shareholders with a registered address in the Approved Jurisdictions and in accordance with the conditions of the Prospectus.
By clicking “I Accept” below, you acknowledge and agree that: